SSI INVESTMENT MANAGEMENT LLC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2. A total of 13 filers reported holding ENDOLOGIX INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
SSI INVESTMENT MANAGEMENT LLC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q2 2018$1,828,000
+6.3%
2,000,0000.0%0.15%
+7.1%
Q1 2018$1,719,000
-41.7%
2,000,000
-38.6%
0.14%
-43.1%
Q4 2017$2,951,000
+5.5%
3,256,0000.0%0.25%
+2.9%
Q3 2017$2,796,000
+0.4%
3,256,0000.0%0.24%
-2.4%
Q2 2017$2,786,000
-13.4%
3,256,0000.0%0.24%
-16.9%
Q1 2017$3,217,000
+22.7%
3,256,000
+8.5%
0.30%
+22.9%
Q4 2016$2,621,000
-57.2%
3,000,000
-35.1%
0.24%
-55.7%
Q3 2016$6,126,000
+1.8%
4,626,0000.0%0.54%
-5.9%
Q2 2016$6,015,000
+32.5%
4,626,000
-2.6%
0.58%
+23.9%
Q1 2016$4,539,000
+5.4%
4,750,000
+18.8%
0.46%
+5.4%
Q4 2015$4,308,0004,000,0000.44%
Other shareholders
ENDOLOGIX INC shareholders Q2 2017
NameSharesValueWeighting ↓
SILVERBACK ASSET MANAGEMENT LLC 4,000,000$3,760,0000.56%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ENDOLOGIX INC shareholders